Towa Pharmaceutical Co., Ltd. (FRA:6QC)

Towa Pharmaceutical Statistics

Total Valuation

FRA:6QC has a market cap or net worth of EUR 1.16 billion. The enterprise value is 2.22 billion.

Market Cap	1.16B
Enterprise Value	2.22B

Important Dates

The last earnings date was Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	Sep 29, 2025

Share Statistics

Current Share Class	49.23M
Shares Outstanding	n/a
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	23.01M

Valuation Ratios

The trailing PE ratio is 9.98.

PE Ratio	9.98
Forward PE	n/a
PS Ratio	0.79
PB Ratio	1.13
P/TBV Ratio	1.46
P/FCF Ratio	33.76
P/OCF Ratio	6.94
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.78, with an EV/FCF ratio of 64.61.

EV / Earnings	19.10
EV / Sales	1.50
EV / EBITDA	8.78
EV / EBIT	16.83
EV / FCF	64.61

Financial Position

The company has a current ratio of 2.83, with a Debt / Equity ratio of 1.23.

Current Ratio	2.83
Quick Ratio	1.30
Debt / Equity	1.23
Debt / EBITDA	n/a
Debt / FCF	36.87
Interest Coverage	11.24

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	6.43%
Return on Capital Employed (ROCE)	6.10%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	306,237
Profits Per Employee	24,329
Employee Count	4,788
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, FRA:6QC has paid 38.05 million in taxes.

Income Tax	38.05M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +27.87% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+27.87%
50-Day Moving Average	19.63
200-Day Moving Average	17.67
Relative Strength Index (RSI)	78.85
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:6QC had revenue of EUR 1.47 billion and earned 116.49 million in profits. Earnings per share was 2.37.

Revenue	1.47B
Gross Profit	538.36M
Operating Income	131.04M
Pretax Income	154.53M
Net Income	116.49M
EBITDA	251.22M
EBIT	131.04M
Earnings Per Share (EPS)	2.37

Balance Sheet

The company has 216.30 million in cash and 1.27 billion in debt, with a net cash position of -1.05 billion.

Cash & Cash Equivalents	216.30M
Total Debt	1.27B
Net Cash	-1.05B
Net Cash Per Share	n/a
Equity (Book Value)	1.03B
Book Value Per Share	20.93
Working Capital	930.25M

Cash Flow

In the last 12 months, operating cash flow was 167.47 million and capital expenditures -133.04 million, giving a free cash flow of 34.43 million.

Operating Cash Flow	167.47M
Capital Expenditures	-133.04M
Free Cash Flow	34.43M
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	8.94%
Pretax Margin	10.54%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	2.35%

Dividends & Yields

This stock pays an annual dividend of 0.47, which amounts to a dividend yield of 2.03%.

Dividend Per Share	0.47
Dividend Yield	2.03%
Dividend Growth (YoY)	28.70%
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-0.01%
Shareholder Yield	2.02%
Earnings Yield	10.02%
FCF Yield	2.96%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5